Although acute toxicity studies in animals are an indispensable prerequisite for the realisation of clinical trials in humans, these can only be projected to humans to a limited extent, and thus are scientifically problematic and ethically questionable. Therefore, the international regulat ... more
Dr. Julia Frühwald
studied biology at the University of Kaiserslautern, and in 2010 received her doctorate as Dr. rer. Nat. from the Institute for Experimental and Clinical Pharmacology and Toxicology at Saarland University. Since 2011, she has been working as Project Coordinator R&D for Pharmacelsus GmbH in Saarbrücken. She coordinates and is responsible for international and national research projects, in which Pharmacelsus is a cooperation partner. The aim of these innovative projects is the research and development of new potential drugs, in collaboration with academic or industrial partners.